Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Multiplicity

After years of growing momentum, 2015 saw the biosimilar genie fully emerge from the bottle

- PMLiVE

The tribe has spoken

Who gets to decide which profit margin is acceptable?

- PMLiVE

Size matters?

Pfizer’s $160bn deal to acquire Allergan will challenge the new company to show that big is better

- PMLiVE

Brand teams: They’re not what you think they are

Head of Commercial Matt Bolton of Blue Latitude Health breaks down what we mean when we talk about eliminating the last silos in pharma marketing.

Blue Latitude Health

Blue Latitude Health to sponsor and co-present in the Innovation Track at ProcureCon Healthcare 2016

Blue Latitude Health’s Managing Director, Martin Brass, and Johnson & Johnson’s Director, David McKimm, to co-present on the topic “Optimising Your Marketing Spend in New Ways to Create Value for...

Blue Latitude Health

- PMLiVE

NICE wants more data on Alexion’s orphan drug Kanuma

Calls for 'robust evidence' about the costly rare disease treatment's price and benefits

- PMLiVE

Stem cell therapy promising for rheumatoid arthritis

Mesoblast’s phase II trial sees "impressive efficacy" in refractory patients

- PMLiVE

The hidden costs of poor translation

How to ensure that outsourcing really adds up to cost-saving

- PMLiVE

The EMA’s literature screening service and pharma

Complexities and new potential in pharmacovigilance

- PMLiVE

A five-step plan for patient-centred digital communications

Every functional area should be able to interact with patients

- PMLiVE

Changing the game in multichannel marketing

Blowing the whistle on pharma’s road to the new normal

- PMLiVE

Reflections on marketing excellence

Looking back over 20 years of change in pharma marketing

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links